Evidence map›Paper›PMID 40454042›Full record

ArticleACS omega2025

Gold Nanoparticle-DNA Conjugates: An Enzymatic DNA Synthesis Platform.

Luiz Henrique Mesquita Souza, Ianca Rosa Dias, Cyro von Zuben de Valega Negrão, Henrique da Costa Oliveira, Paula Cristina Gasperazzo Turrini, André Guilherme da Costa Martins, João Lucas Maehara Said Dos Reis, Eric André Velasco Yepez, Bruno Nobuya Katayama Gobara, Caio José Perecin and 3 more

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Engineering a Virus-Derived X Family DNA Polymerase FvPolX for de novo DNA Synthesis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Luiz Henrique Mesquita SouzaInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.ORCID https://orcid.org/0000-0002-4232-7373
Ianca Rosa DiasInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.
Cyro von Zuben de Valega NegrãoInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.ORCID https://orcid.org/0000-0002-3921-4378
Henrique da Costa OliveiraInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.
Paula Cristina Gasperazzo TurriniInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.
André Guilherme da Costa MartinsInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.
João Lucas Maehara Said Dos ReisInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.
Eric André Velasco YepezInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.ORCID https://orcid.org/0000-0003-3808-2841
Bruno Nobuya Katayama GobaraInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.
Caio José PerecinInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.
João Bosco PesqueroInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.
Bruno Marinaro VeronaInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.
Natália Neto Pereira CerizeInstitute for Technological Research (IPT)-Bionanomanufacturing Center (BIONANO), São Paulo 05508-901, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leveraging the well-established properties of gold nanoparticle (AuNP)-DNA conjugates, this research explored a novel methodology for controlled enzymatic DNA synthesis using gold nanoparticle (AuNP)-DNA conjugates as a solid platform. To this end, Hybrid Nanoparticles (HNPs) were meticulously engineered through the functionalization of AuNPs with rationally designed DNA initiator molecules. These initiator molecules, strategically attached to the AuNP surface, served as a physical support and starting point for DNA extension by the Terminal Deoxynucleotidyl Transferase (TdT) enzyme. The results confirmed the synthesis of homopolymeric DNA extensions on these HNPs (58.27 nm, PDI < 0.2), demonstrating the viability of HNPs as a platform for enzymatic DNA elongation. Although the growing demand for data storage suggests a potential application, this research established the foundational feasibility of enzymatic DNA synthesis on HNPs. While high-density DNA data storage requires extensive development, the demonstrated enzymatic synthesis on AuNP-DNA conjugates warrants significant further exploration for future applications in biotechnology and nanotechnology.

Identifiers

PMID40454042
PMCPMC12120612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.